SCHEMBL7306087

SCHEMBL7306087

CC1(C)O[C@@H]([C@H](CSc2ccc3ccccc3c2)OS(C)(=O)=O)[C@H]([C@H](CSc2ccc3ccccc3c2)OS(C)(=O)=O)O1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
CNR2 P34972 1/20 0.37
BACE1 P56817 8/20 0.34
ANPEP P15144 1/20 0.34
MAPT P10636 4/20 0.32
ALDH1A1 P00352 3/20 0.32
POLB P06746 1/20 0.32
LMNA P02545 2/20 0.32
EPHX1 P07099 1/20 0.32
CASP1 P29466 1/20 0.31
CASP3 P42574 1/20 0.31
CASP7 P55210 1/20 0.31
CASP6 P55212 1/20 0.31
CASP8 Q14790 1/20 0.31
G6PD P11413 1/20 0.31
CCR6 P51684 1/20 0.31
HKDC1 Q2TB90 1/20 0.31
PLA2G10 O15496 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7306681 0.81 HTR2A (0.41)
SCHEMBL7306558 0.77 CYP3A4 (0.45) CYP3A4CYP2C9CYP2C19BACE1ANPEP
SCHEMBL7309489 0.71 ANPEP (0.35) CYP3A4ANPEP
SCHEMBL9364522 0.64 ALDH1A1 (0.35) ALDH1A1
SCHEMBL7305088 0.64 BACE1 (0.49) CYP3A4CYP2C9CYP2C19BACE1ANPEP
Ammonia Solution, Strong SCHEMBL7243545 0.64 CYP3A4 (0.49) CYP3A4CYP2C9CYP2C19CNR2BACE1
SCHEMBL5950493 0.63 ANPEP (0.41) CYP3A4CYP2C9CYP2C19CNR2ANPEP
SCHEMBL20495593 0.61 CYP3A4 (0.50) CYP3A4CYP2C9CYP2C19CNR2BACE1
SCHEMBL7305610 0.61 HTR2A (0.47)
SCHEMBL20088011 0.60 BACE1 (0.58) CYP3A4CYP2C9CYP2C19CNR2BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575097-B1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5578608-A HIV PROTEASE INHIBITOR ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
EP-0575097-A1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS ELI LILLY AND COMPANY (US) 1993-12-22 EP disclosed